Lymphoma is a common disease in companion animals. Although conventional chemotherapy has the potential to induce remission and prolong life, relapse is common, and novel treatments are needed to improve outcome. This review discusses recent modifications/adjustments to conventional standard of care therapy for canine and feline lymphoma, as well as cutting-edge immunotherapy and small-molecule-based approaches that are in varying stages of regulatory approval.

中文翻译：

---

淋巴瘤的新疗法。

淋巴瘤是伴侣动物的常见疾病。尽管常规化学疗法有可能诱发缓解并延长寿命，但复发很常见，需要新的疗法来改善预后。这篇综述讨论了对犬和猫淋巴瘤常规治疗标准的最新修改/调整，以及处于不同法规批准阶段的尖端免疫疗法和基于小分子的方法。